PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 113 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,931,000 | -73.4% | 483,437 | -66.1% | 0.04% | -71.4% |
| Q1 2018 | $18,552,000 | -9.1% | 1,427,061 | +25.2% | 0.15% | -4.9% |
| Q4 2017 | $20,401,000 | -11.3% | 1,139,712 | +24.4% | 0.16% | -5.8% |
| Q3 2017 | $23,000,000 | +497.1% | 916,349 | +473.4% | 0.17% | +437.5% |
| Q2 2017 | $3,852,000 | – | 159,814 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |